Adam Levy
Vermogen: 55 437 $ op 30-09-2026
Vermogen: 55 437 $ op 30-09-2026
Mr. Adam S.
Levy is a Chief Financial Officer at Mineralys Therapeutics, Inc. He is on the Board of Directors at Praxis Bioresearch LLC.
Mr. Levy was previously employed as a Chief Business Officer by Vical, Inc., a Chief Business Officer by Brickell Subsidiary, Inc., a Chief Business Officer by Fresh Tracks Therapeutics, Inc., a Chief Business Officer by Miragen Therapeutics, Inc., a Senior Vice President by Merrill Lynch, Pierce, Fenner & Smith, Inc., a Vice President-Healthcare Investment Banking by Wedbush Securities, Inc., and a Chief Financial Officer by Sanifit Therapeutics SA. He received his undergraduate degree from Cornell University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-03-2026 | 2.206 ( 0% ) | 55 437 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-03-2022 |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel prodrug stimulants for treatment of chronic neuropsychiatric and neurodegenerative disorders | Directeur/Bestuurslid | 19-09-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Financieel Directeur/CFO | 01-01-2022 |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Corporate Officer/Principal | 01-01-2020 |
| VIRIDIAN THERAPEUTICS, INC. | Investor Relations Contact | - |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01-05-2016 |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Corporate Officer/Principal | 01-04-2011 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops and manufactures prescription therapeutics products for treatment of autoimmune, inflammatory and debilitating diseases | Health Technology |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel prodrug stimulants for treatment of chronic neuropsychiatric and neurodegenerative disorders | Health Technology |
Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau